Nineteen patiens (20 eyes) with the exudative form of macular degeneration were treated with parenteral interferon alfa-2a. Fifteen patients (16 eyes) had adequate follow-up for evaluation of outcome of the exudative macular lesion. The average follow-up was 8 months (range 5-11 months). Color photographs and fluorescein angiograms were evaluated independently by two masked readers for change in size, presence of fibrosis, and leakage of the neovascular lesion. During the follow-up, none of the exudative lesions resolved: one lesion became smaller, four remained the same, nine enlarged, and two could not be graded based on the photographs. Visual acuity remained 20/40 or better in four eyes. The proportion of eyes with visual acuity of 20/200 or worse increased from 35% at the initial visit to 59 % at the final visit. Ten patients experienced significant but reversible side effects, including weight loss, depression, and/or hematopoietic suppression. The data from these cases do not support any significant treatment benefit from interferon alfa-2a at the doses used in exudative macular degeneration.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Abrams DI, Volberding PA (1986) Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol 13 [Suppl 2]:43–47
Bressler NM, Frost LA, Bressler SB, et al. (1988) Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 106:1537–1542
Brouty-Boyé D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516–518
Claessens DA, Miller JW, Woods WJ, Folkman J (1992) Alpha-interferon treatment of experimental choroidal neovascularization. ARVO abstracts. Invest Ophthalmol Vis Sci 33:1207
Folkman J (1989) Successful treatment of an angiogenic disease. N Engl J Med 320:1211–1212
Friesel R, Komoriya A, Maciag T (1987) Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 104:689–696
Fung WE (1991) Interferon Alpha 2a for treatment of agerelated macular degeneration. Am J Ophthalmol 112:349–350
Gass JDM (1984) Serous retinal pigment epithelial detachment with a notch: a sign of occult choroidal neovascularization. Retina 4:205–220
Heyns A duP, Elder A, Vlodavsky I, Kaiser N, Fridman R, Panet H (1985) The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells. Exp Cell Res 161:297–306
Lewis ML, Pautler S (1988) Retinal pigment epithelial detachments with choroidal neovascular membranes in age-related macular degeneration: natural history versus laser photocoagulation. In: Gitter KA, Schatz H, Yannuzzi LA, McDonald HR (eds) Laser photocoagulation of retinal disease. Pacific Medical Press, San Francisco, pp 207–216
Loughnan MS, Heriot WJ, O'Day J (1992) Treatment of subfoveal choroidal neovascular membranes with systemic interferon-α 2a. Aust NZ J Ophthalmol 20:173–175
Macular Photocoagulation Study Group (1991) Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 109:1220–1231
Singerman LJ, Stockfish JH (1989) Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 227:501–507
Soubrane G, Coscas G, Francais C, Koenig F (1990) Occult subretinal new vessels in age-related macular degeneration: natural history and early laser treatment. Ophthalmology 97:649–657
White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alpha-2a. N Engl J Med 320:1197–1200
About this article
Cite this article
Lewis, M.L., Davis, J. & Chuang, E. Interferon alfa-2a in the treatment of exudative age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 231, 615–618 (1993). https://doi.org/10.1007/BF00921954
- Visual Acuity
- Macular Degeneration
- Initial Visit
- Final Visit
- Color Photograph